Alto Neuroscience, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Alto Neuroscience promoted CFO Nicholas C. Smith to President and CFO effective August 26, 2026. Smith receives a $6M retention payment in two equal $3M installments (first within 10 days, second on one-year anniversary), contingent on continuous employment through August 26, 2028. If Smith resigns or is terminated for Cause before the retention date, he must repay all amounts received; if terminated without Cause or due to death/disability, remaining payments are owed.
Why this rating
Retention package ($6M) equals ~11% of company's $55.2M market cap. Leadership continuity matters for small-cap biotech, but promotion is internal with standard clawback terms, reducing downside risk.
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.